AndradeRG,RibeiroMA,Namen-LopesMS,SilvaSM,BasquesFV,RibasJG, 2010.Evaluation of the use of realtime PCR for human T cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors,Rev Soc Bras Med Trop 43 111 -15
AcarA,KemahliS,AltunayH,KosanE,OnculO,GorenekL, 2010.HBV, HCV and HIV seroprevalence among blood donors in Istanbul, Turkey: how effective are the changes in the national blood transfusion policies?,Bra J Inf Dis 14 41 -46
MontagT., 2008.Strategies of bacteria screening in cellular blood components,Clin Chem Lab Med 46 926 -32
PalavecinoE,YomtovianR, 2003.Risk and prevention of transfusion-related sepsis,Curr Opin Hematol 10 434 -39
SusanneM., 2013.Current methods for the reduction of bloodborne pathogens:a comprehensive literature review,Blood Transfus 11 343 -48
Schlenke P. Pathogen, 2014.Inactivation Technologies for Cellular Blood Components: an Update,Transfus Med Hemother 41 309 -25
ChaudharyHT, 2017.Blood Bag's protection from bacteria: Review,Prof Med 24 210 -15
SobralPM,BarrosAE,GomesAM,BonfimCV, 2012.Viral inactivation in hemotherapy: systematic review on inactivators with action on nucleic acids,Rev Bras Hematol Hemoter 34 231 -35
SpringerTA,ZhuJ,XiaoT., 2008.Structural basis for distinctive recognition of fi brinogen γC peptide by the platelet integrin αIIbβ3,J Cell Biol 182 791 -800
ChaudharyHT,HasnainS.,In-SilicoAnalysis, 2016.Analysis Of S303 Binding To CD-61 Of Platelets,Prof Med 23 217 -22
ChaudharyHT, 2016.In-silico analysis of Amotosalen Hydrochloride binding to CD-61 of platelets,J Coll Phys Surg Pak 26 881 -86
Schneidman-DuhovnyD,InbarY,NussinovR,WolfsonHJ, 2005.PatchDock and SymmDock: servers for rigid and symmetric docking,Nucleic Acids Res 33 363 -67
MashiachE,Schneidman-DuhovnyD,AndrusierN,NussinovR,WolfsonHJ, 2008.FireDock: a web server for fast interaction refinement in molecular docking,Nucleic Acids Res 36 229 -32
EpsteinJS,VostalJG, 2003.FDA approach to evaluation of pathogen reduction technology,Transfusion 43 1347 -50
SpringerTA,ZhuJ,XiaoT, 2008.Structural Basis for Distinctive Recognition of Fibrinogen Gammac Peptide by the Platelet Integrin Alphaiibbeta3,J Cell Biol 182 791 -
Spain: DeLano ScientificLLC, 2006., -
SA, .Website:,Biotechnology Information; 2006 July 30 -
EMBL-EBI, 1992., -
EMBL-EBI, 1992.Protein Data Bank in Europe, -
ParidaP,YadavRNS, 2012.Comparative docking study of m1 protein (influenza virus) to check drug efficacy,Int J Pharm Pharm Sci 4 243 -46
PatilR,DasS,StanleyA,YadavL,SudhakarA,VarmaAK, 2010.Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing,PLoS ONE 5 e12029 -